vs 9,698 other HR bills in the 117th — cohort avg 63d
Summary
Comprehensive Care for Alzheimer's Act This bill allows the Center for Medicare and Medicaid Innovation (CMMI) to test a Dementia Care Management Model that provides comprehensive care to Medicare beneficiaries with Alzheimer's disease or a related dementia. Under the model, participating health care providers receive payment under Medicare for comprehensive care management services that are provided to individuals with diagnosed dementia, excluding Medicare Advantage enrollees, hospice care recipients, and nursing home residents. Required services include medication management, care coordination, and health, financial, and environmental monitoring, as well as trainings and other support services for unpaid caregivers. Providers must furnish services through interdisciplinary teams and must ensure access to a team member or primary care provider 24-7. The CMMI must set payments and determine quality measures for the model in accordance with specified requirements. The bill also allows the CMMI to design a similar model under Medicaid.
Lobbying filings that explicitly cite this bill (35)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Cited source text, amounts, lobbyists, and targets
S.56/H.R. 1474 Alzheimer's Caregiver Support Act Americans Giving Care to Elders (AGE) Act of 2021 (H.R. 3689/S. 234) S.104 Improving Social Determinants of Health Act of 2021 National Coronavirus Commission Act of 2021 (H.R. 1306/S. 412) Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57) NIH supplemental funding S.333 COVID-19 Nursing Home Protection Act of 2021 S.962 American Cures Act S.674 Public Health Infrastructure Saves Lives Act FDA Neuroscience Center of Excellence BRAIN Initiative funding PACE Plus Act (S. 1162) Nursing Home Reform Modernization Act (H.R. 1985/ S. 782) Homecare for Seniors Act (H.R. 2898/S. 1399) COVID HCBS Relief Act of 2021 (H.R. 525/S. 151) Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021 Credit for Caring Act (H.R. 3321/S. 1670) Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125) Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548) Elder Abuse Protection Act of 2021 (H.R. 2922) Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904) PROTECTS Act (S. 2214) Provider Training in Palliative Care Act (S. 2890) Choose Home Care Act of 2021 (S. 2562/H.R 5514) Direct Care Opportunity Act (H.R. 2999) Inflation Reduction Act of 2022 (H.R.5376) Cures 2.0 Act (H.R. 6000) Innovation in Aging Act (S. 3473) Revitalizing the Aging Network Act (S. 3431) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706/H.R. 5030) Stop the Wait Act of 2022 (S. 3575/H.R. 6583) Palliative Care and Hospice Education and Training Act (S. 4260) NAPA Reauthorization Act (H.R. 7775/S. 4203) Alzheimer's Accountability and Investment Act (H.R. 7773/S. 4202) IMPROVE Nursing Homes Act (H.R. 8677) Kevin and Avonte's Reauthorization Act of 2022 (H.R. 8907/S. 4885) Modernizing Accelerated Approval Pathway Act (S. 4446) Mandating Exclusive Review of Individual Treatments (MERIT) Act (H.R. 9127) Access to Innovative Treatments Act of 2022 (H.R. 9358) Consolidated Appropriations Act, 2023 (H.R. 2617) National Concussion Surveillance System (NCSS) funding at the CDC Other matters related to COVID -19 and long COVID Other matters related to elder justice Other matters related to dementia care management models Other matters related to younger-onset Alzheimer's disease Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to home- and community-based services Other matters related to diversity in clinical trials Other matters related to caregiving Other matters related to biomedical research, Alzheimer's diagnostics, and patient-focused drug development Other matters related to Social Security Other matters related to related to user fee agreements and accelerated approval
Client expense: $490,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
Text of the Senate Amendment to the House Amendment to the Senate Amendment to H.R. 4346, Supreme Court Funding Act of 2022, became known as the CHIPS and Science Act (support - Division B, Titles I, II, III, V, and VI) HR 2517, FY2023 Consolidated Appropriations Act, P.L. 117-328 (Support) HR 5721, VIPER Act of 2021 (Support)
Client expense: $70,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
HR 2517 - FY 2023 Consolidated Appropriations Act, P.L. 117-328 (support) HR 5721, VIPER Act of 2021 (Support) Text of the Senate Amendment to the House Amendment to the Senate Amendment to H.R. 4346, Supreme Court Funding Act of 2022, became known as the CHIPS and Science Act (support - Division B, Titles I, II, III, V, and VI)
Client expense: $70,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
S.56/H.R. 1474 Alzheimer's Caregiver Support Act Americans Giving Care to Elders (AGE) Act of 2021 (H.R. 3689/S. 234) S.104 Improving Social Determinants of Health Act of 2021 National Coronavirus Commission Act of 2021 (H.R. 1306/S. 412) Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57) NIH supplemental funding S.333 COVID-19 Nursing Home Protection Act of 2021 S.962 American Cures Act S.674 Public Health Infrastructure Saves Lives Act FDA Neuroscience Center of Excellence BRAIN Intiative funding PACE Plus Act (S. 1162) Nursing Home Reform Modernization Act (H.R. 1985/ S. 782) Homecare for Seniors Act (H.R. 2898/S. 1399) COVID HCBS Relief Act of 2021 (H.R. 525/S. 151) Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021 Credit for Caring Act (H.R. 3321/S. 1670) Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125) Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548) Elder Abuse Protection Act of 2021 (H.R. 2922) Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904) PROTECTS Act (S. 2214) Provider Training in Palliative Care Act (S. 2890) Choose Home Care Act of 2021 (S. 2562/H.R 5514) Direct Care Opportunity Act (H.R. 2999) Inflation Reduction Act of 2022 (H.R.5376) Cures 2.0 Act (H.R. 6000) Innovation in Aging Act (S. 3473) Revitalizing the Aging Network Act (S. 3431) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706/H.R. 5030) Stop the Wait Act of 2022 (S. 3575/H.R. 6583) Palliative Care and Hospice Education and Training Act (S.4260) NAPA Reauthorization Act (H.R. 7775/S 4203) Alzheimer's Accountability and Investment Act (H.R. 7773/S 4202) IMPROVE Nursing Homes Act (H.R. 8677) Kevin and Avonte's Reauthorization Act of 2022 (H.R. 8907/S. 4885) Mandating Exclusive Review of Individual Treatments (MERIT) Act (H.R. 9127) Other matters related to COVID -19 and long COVID Other matters related to elder justice Other matters related to dementia care management models Other matters related to younger-onset Alzheimer's disease Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to home- and community-based services Other matters related to diversity in clinical trials Other matters related to caregiving Other matters related to biomedical research, Alzheimer's diagnostics, and patient-focused drug development Other matters related to Social Security Other matters related to related to user fee agreements and accelerated approval
Client expense: $690,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 2517/S. 1125: A bill to recommend that the Center for Medicare and Medicaid Innovation test the effect of a dementia care management model H.R.3085/S.1548, the Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S.1692/H.R.3354, the Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act S. 1125/H.R. 2517, recommends that the Center for Medicare and Medicaid Innovation (CMMI) test the effect of different dementia care management model and reimbursement strategies
Client expense: $43,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
FY 2023 Appropriations for HHS; FY 2023 Continuing Resolution S. 56/H.R. 1474, the Alzheimer's Caregiver Support Act H.R. 2517/S.1125 Comprehensive Care for Alzheimer's Act S. 4203/H.R. 7775, the Reauthorization of NAPA Act
Client expense: $43,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
S.56/H.R. 1474 Alzheimer's Caregiver Support Act Americans Giving Care to Elders (AGE) Act of 2021 (H.R. 3689/S. 234) S.104 Improving Social Determinants of Health Act of 2021 National Coronavirus Commission Act of 2021 (H.R. 1306/S. 412) Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57) NIH supplemental funding S.333 COVID-19 Nursing Home Protection Act of 2021 S.962 American Cures Act S.674 Public Health Infrastructure Saves Lives Act FDA Neuroscience Center of Excellence BRAIN Intiative funding PACE Plus Act (S. 1162) Nursing Home Reform Modernization Act (H.R. 1985/ S. 782) Homecare for Seniors Act (H.R. 2898/S. 1399) COVID HCBS Relief Act of 2021 (H.R. 525/S. 151) Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021 Credit for Caring Act (H.R. 3321/S. 1670) Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125) Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548) Elder Abuse Protection Act of 2021 (H.R. 2922) Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904) PROTECTS Act (S. 2214) Provider Training in Palliative Care Act (S. 2890) Choose Home Care Act of 2021 (S. 2562/H.R 5514) Direct Care Opportunity Act (H.R. 2999) Build Back Better Act (H.R.5376) Cures 2.0 Act (H.R. 6000) Innovation in Aging Act (S. 3473) Revitalizing the Aging Network Act (S. 3431) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706/H.R. 5030) Stop the Wait Act (S. 3575/H.R. 6583) Palliative Care and Hospice Education and Training Act (S.4260) NAPA Reauthorization Act (H.R. 7775/S 4203) Alzheimer's Accountability and Investment Act (H.R. 7773/S 4202) Other matters related to COVID -19 and long COVID Other matters related to elder justice Other matters related to dementia care management models Other matters related to younger-onset Alzheimer's disease Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to home- and community-based services Other matters related to diversity in clinical trials Other matters related to caregiving Other matters related to biomedical research, Alzheimer's diagnostics, and patient-focused drug development Other matters related to Social Security Other matters related to related to user fee agreements and accelerated approval
Cited source text, amounts, lobbyists, and targets
S.56/H.R. 1474 Alzheimer's Caregiver Support Act Americans Giving Care to Elders (AGE) Act of 2021 (H.R. 3689/S. 234) S.104 Improving Social Determinants of Health Act of 2021 National Coronavirus Commission Act of 2021 (H.R. 1306/S. 412) Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57) NIH supplemental funding S.333 COVID-19 Nursing Home Protection Act of 2021 S.962 American Cures Act S.674 Public Health Infrastructure Saves Lives Act FDA Neuroscience Center of Excellence BRAIN Intiative funding PACE Plus Act (S. 1162) Nursing Home Reform Modernization Act (H.R. 1985/ S. 782) Homecare for Seniors Act (H.R. 2898/S. 1399) COVID HCBS Relief Act of 2021 (H.R. 525/S. 151) Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021 Credit for Caring Act (H.R. 3321/S. 1670) Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125) Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548) Elder Abuse Protection Act of 2021 (H.R. 2922) Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904) PROTECTS Act (S. 2214) Provider Training in Palliative Care Act (S. 2890) Choose Home Care Act of 2021 (S. 2562/H.R 5514) Direct Care Opportunity Act (H.R. 2999) Build Back Better Act (H.R.5376) Cures 2.0 Act (H.R. 6000) Innovation in Aging Act (S. 3473) Revitalizing the Aging Network Act (S. 3431) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706/H.R. 5030) Stop the Wait Act (S. 3575/H.R. 6583) Palliative Care and Hospice Education and Training Act (S.4260) NAPA Reauthorization Act (H.R. 7775/S 4203) Alzheimer's Accountability and Investment Act (H.R. 7773/S 4202) Other matters related to COVID -19 and long COVID Other matters related to elder justice Other matters related to dementia care management models Other matters related to younger-onset Alzheimer's disease Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to home- and community-based services Other matters related to diversity in clinical trials Other matters related to caregiving Other matters related to biomedical research, Alzheimer's diagnostics, and patient-focused drug development Other matters related to Social Security Other matters related to related to user fee agreements and accelerated approval
Cited source text, amounts, lobbyists, and targets
FY 2023 Appropriations for HHS; S. 56/H.R. 1474, the Alzheimer's Caregiver Support Act H.R. 2517/S.1125 Comprehensive Care for Alzheimer's Act S. 4203/H.R. 7775, the Reauthorization of NAPA Act
Client expense: $45,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 2517/S. 1125: A bill to recommend that the Center for Medicare and Medicaid Innovation test the effect of a dementia care management model H.R.3085/S.1548, the Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S.1692/H.R.3354, the Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act S. 1125/H.R. 2517, recommends that the Center for Medicare and Medicaid Innovation (CMMI) test the effect of different dementia care management model and reimbursement strategies
Client expense: $45,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
S.56/H.R. 1474 Alzheimer's Caregiver Support Act Americans Giving Care to Elders (AGE) Act of 2021 (H.R. 3689/S. 234) S.104 Improving Social Determinants of Health Act of 2021 National Coronavirus Commission Act of 2021 (H.R. 1306/S. 412) Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57) NIH supplemental funding S.333 COVID-19 Nursing Home Protection Act of 2021 S.962 American Cures Act S.674 Public Health Infrastructure Saves Lives Act FDA Neuroscience Center of Excellence BRAIN Intiative funding PACE Plus Act (S. 1162) Nursing Home Reform Modernization Act (H.R. 1985/ S. 782) Homecare for Seniors Act (H.R. 2898/S. 1399) COVID HCBS Relief Act of 2021 (H.R. 525/S. 151) Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021 Credit for Caring Act (H.R. 3321/S. 1670) Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125) Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548) Elder Abuse Protection Act of 2021 (H.R. 2922) Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904) PROTECTS Act (S. 2214) Provider Training in Palliative Care Act (S. 2890) Choose Home Care Act of 2021 (S. 2562/H.R 5514) Direct Care Opportunity Act (H.R. 2999) Build Back Better Act (H.R.5376) Cures 2.0 Act (H.R. 6000) Innovation in Aging Act (S. 3473) Revitalizing the Aging Network Act (S. 3431) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706/H.R. 5030) Stop the Wait Act (S. 3575/H.R. 6583) Other matters related to elder justice Other matters related to dementia care management models Other matters related to younger-onset Alzheimer's disease Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to home- and community-based services Other matters related to diversity in clinical trials Other matters related to caregiving Other matters related to biomedical research, Alzheimer's diagnostics, and patient-focused drug development Other matters related to Social Security Other matters related to related to user fee agreements and accelerated approval
Cited source text, amounts, lobbyists, and targets
S.2999 A bill to prohibit the Secretary of Health and Human Services, any officer or employee of the Department of Health and Human Services, and States from requiring COVID-19 vaccination as a condition of eligibility for benefits or assistance under the Medicare, Medicaid, or CHIP program; S.J.Res.32 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination";H.R.1677 To direct the Secretary of Health and Human Services, the Medicare Payment Advisory Commission, and the Medicaid and CHIP Payment and Access Commission to conduct studies and report to Congress on actions taken to expand access to telehealth services under the Medicare, Medicaid, and Children's Health Insurance programs during the COVID-19 emergency; . S.620 KEEP Telehealth Options Act of 2021; S104 HR379 Improving Social Determinants of Health Act of 2021; H.R.2517, S1125 To recommend that the Center for Medicare and Medicaid Innovation test the effect of a dementia care management model, and for other purposes; H.R.1227, S386 Medicare-X Choice Act of 2021; HR 3322-S826 Medicare Patient Empowerment Act of 2021; HR2410 Medicare & You Handbook Improvement Act of 2021; S1180 Choose Medicare Act' S748 Medicare Sequester Relief Act; HR 315 Medicare Sequester COVID Moratorium Act; HR599 Protecting Medicare Beneficiaries with Pre-Existing Conditions Act; S.2146 Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021; S.4067 A bill to amend title XI of the Social Security Act to improve access to care for all Medicare and Medicaid beneficiaries through models tested under the Center for Medicare and Medicaid Innovation, and for other purposes.
Cited source text, amounts, lobbyists, and targets
H.R. 2517/S. 1125: A bill to recommend that the Center for Medicare and Medicaid Innovation test the effect of a dementia care management model H.R.3085/S.1548, the Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S.1692/H.R.3354, the Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act
Client expense: $45,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
S.56/H.R. 1474 Alzheimer's Caregiver Support Act
Americans Giving Care to Elders (AGE) Act of 2021 (H.R. 3689/S. 234)
S.104 Improving Social Determinants of Health Act of 2021
National Coronavirus Commission Act of 2021 (H.R. 1306/S. 412)
Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57)
NIH supplemental funding
S.333 COVID-19 Nursing Home Protection Act of 2021
S.962 American Cures Act
S.674 Public Health Infrastructure Saves Lives Act
FDA Neuroscience Center of Excellence
BRAIN Intiative funding
PACE Plus Act (S. 1162)
Nursing Home Reform Modernization Act (H.R. 1895/ S. 782)
Homecare for Seniors Act (H.R. 2898/S. 1399)
COVID HCBS Relief Act of 2021 (H.R. 525/S. 151)
Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021
Credit for Caring Act (H.R. 3321/S. 1670)
Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125)
Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548)
Elder Abuse Protection Act of 2021 (H.R. 2922)
Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904)
PROTECTS Act (S. 2214)
Provider Training in Palliative Care Act (S. 2890)
Choose Home Care Act of 2021 (S. 2562/H.R 5514)
Direct Care Opportunity Act (H.R. 2999)
Build Back Better Act (H.R.5376)
Cures 2.0 Act (H.R. 6000)
other matters related to Alzheimer's diagnostics
other matters related to elder justice
other matters related to dementia care management models
other matters related to younger-onset Alzheimer's disease
other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease
other matters related to home- and community-based services
other matters related to diversity in clinical trials
other matters related to caregiving
other matters related to patient-focused drug development
other matters related to biomedical research
other matters related to Social Security
Cited source text, amounts, lobbyists, and targets
S.2999 A bill to prohibit the Secretary of Health and Human Services, any officer or employee of the Department of Health and Human Services, and States from requiring COVID-19 vaccination as a condition of eligibility for benefits or assistance under the Medicare, Medicaid, or CHIP program; S.J.Res.32 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination";H.R.1677 To direct the Secretary of Health and Human Services, the Medicare Payment Advisory Commission, and the Medicaid and CHIP Payment and Access Commission to conduct studies and report to Congress on actions taken to expand access to telehealth services under the Medicare, Medicaid, and Children's Health Insurance programs during the COVID-19 emergency; . S.620 KEEP Telehealth Options Act of 2021; S104 HR379 Improving Social Determinants of Health Act of 2021; H.R.2517, S1125 To recommend that the Center for Medicare and Medicaid Innovation test the effect of a dementia care management model, and for other purposes; H.R.1227, S386 Medicare-X Choice Act of 2021; HR 3322-S826 Medicare Patient Empowerment Act of 2021; HR2410 Medicare & You Handbook Improvement Act of 2021; S1180 Choose Medicare Act' S748 Medicare Sequester Relief Act; HR 315 Medicare Sequester COVID Moratorium Act; HR599 Protecting Medicare Beneficiaries with Pre-Existing Conditions Act; S.2146 Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021.
Client expense: Not reported · Firm income: $11,000
Government targets: Administration on Aging, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
H.R. 2517/S. 1125: A bill to recommend that the Center for Medicare and Medicaid Innovation test the effect of a dementia care management model
H.R.3085/S.1548, the Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act
S.1692/H.R.3354, the Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act
Client expense: $45,000 · Firm income: Not reported
Government targets: Administration on Aging, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
S.56/H.R. 1474 Alzheimer's Caregiver Support Act
Americans Giving Care to Elders (AGE) Act (H.R. 3689/S. 234)
S.104 Improving Social Determinants of Health Act of 2021
National Coronavirus Commission Act (H.R. 1306/S. 412)
Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57)
NIH supplemental funding
S.333 COVID-19 Nursing Home Protection Act of 2021
S.962 American Cures Act
S.674 Public Health Infrastructure Saves Lives Act
FDA Neuroscience Center of Excellence
BRAIN Intiative funding
PACE Plus Act (S. 1162)
Nursing Home Reform Modernization Act (H.R. 1895/ S. 782)
Homecare for Seniors Act (H.R. 2898/S. 1399)
COVID HCBS Relief Act of 2021 (H.R. 525/S. 151)
Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021
Credit for Caring Act (H.R. 3321/S. 1670)
Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125)
Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act (H.R. 3085/S. 1548)
Elder Abuse Protection Act of 2021 (H.R. 2922)
Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904)
PROTECTS Act (S. 2214)
Provider Training in Palliative Care Act (S. 2890)
other matters related to Alzheimer's diagnostics
other matters related to elder justice
other matters related to dementia care management models
other matters related to younger-onset Alzheimer's disease
other matters related to aducanumab
other matters related to home- and community-based services
other matters related to diversity in clinical trials
other matters related to caregiving
Client expense: $350,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R.1677 To direct the Secretary of Health and Human Services, the Medicare Payment Advisory Commission, and the Medicaid and CHIP Payment and Access Commission to conduct studies and report to Congress on actions taken to expand access to telehealth services under the Medicare, Medicaid, and Children's Health Insurance programs during the COVID-19 emergency; . S.620 KEEP Telehealth Options Act of 2021; S104 HR379 Improving Social Determinants of Health Act of 2021; H.R.2517, S1125 To recommend that the Center for Medicare and Medicaid Innovation test the effect of a dementia care management model, and for other purposes; H.R.1227, S386 Medicare-X Choice Act of 2021; HR 3322-S826 Medicare Patient Empowerment Act of 2021; HR2410 Medicare & You Handbook Improvement Act of 2021; S1180 Choose Medicare Act' S748 Medicare Sequester Relief Act; HR 315 Medicare Sequester COVID Moratorium Act; HR599 Protecting Medicare Beneficiaries with Pre-Existing Conditions Act; S.2146 Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021.
Client expense: Not reported · Firm income: $11,000
Cited source text, amounts, lobbyists, and targets
H.R. 2517/S. 1125: A bill to recommend that the Center for Medicare and Medicaid Innovation test the effect of a dementia care management model
H.R.3085/S.1548, the Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act
S.1692/H.R.3354, the Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act
Client expense: $45,000 · Firm income: Not reported
Government targets: Administration on Aging, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Administration on Aging, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
Signed a letter in support of the CONNECT for Health Act 2021 (S.1512)
Signed a letter in support of the Comprehensive Care for Alzheimers Act (S. 1125/H.R. 2517)
Signed a letter from the Medical Imaging and Technology Alliance (MITA) urging the Coverage and Analysis Group within CMS to open the pending reconsideration request for amyloid Positron Emission Tomography (PET) scans.
Signed letter urging the House of Representatives and the Senate to create an out-of-pocket cap in Medicare Part D, reform the Part D exceptions and appeals process, bolster the low-income subsidy program, eliminate cost-sharing for Part D vaccines, and improve information and consumer education for Part D beneficiaries.
Signed a letter as part of the Psychoactive Appropriate Use for Safety and Effectiveness (Project PAUSE) urging CMS to revise the measures of inappropriate use of antipsychotics in skilled nursing facilities and enhance the documentation to support CMSs ability to assess and investigate inappropriate prescribing practices
Submitted letter to Congressional leadership urging an annual out-of-pocket cap in Part D; expansion of low-income subsidy eligibility; placing an inflationary cap in Part D; a requirement that Part D plans share a portion of sales of rebates with beneficiaries at the point of sale; strengthen the Part D appeals process; expand Medicare coverage for dental, vision, and hearing services; and not include the quality-adjusted life year metric in any drug pricing legislation.
Sent letter to House of Representatives leadership urging them not to include International Reference Pricing and Quality-Adjust Life Year metrics in drug pricing legislation.
Met virtually with the House of Representatives and Senate to discuss creating an annual out-of-pocket cap in Medicare Part D, creating a smoothing proposal, and warning against the use of quality-adjusted life-year metrics to determine drug value.
Cited source text, amounts, lobbyists, and targets
S.56/H.R. 1474 Alzheimer's Caregiver Support Act
Americans Giving Care to Elders (AGE) Act
S.104 Improving Social Determinants of Health Act
National Coronavirus Commission Act
Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act
NIH supplemental funding
S.333 COVID-19 Nursing Home Protection Act
S.962 American Cures Act
S.674 Public Health Infrastructure Saves Lives Act
FDA Neuroscience Center of Excellence
BRAIN Intiative funding
PACE Plus Act
Nursing Home Reform Modernization Act
Homecare for Seniors Act
COVID HCBS Relief Act of 2021
Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021
Credit for Caring Act (H.R. 3321/S. 1670)
Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125)
Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act (H.R. 3085/S. 1548)
Elder Abuse Protection Act of 2021 (H.R. 2922)
Reducing COVID-19 Disparities by Investing in Public Health Act
PROTECTS Act (S. 2214)
other matters related to Alzheimer's diagnostics
other matters related to elder justice
other matters related to dementia care management models
other matters related to younger-onset Alzheimer's disease
other matters related to aducanumab
other matters related to home- and community-based services
other matters related to diversity in clinical trials
Client expense: $470,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R.1677 To direct the Secretary of Health and Human Services, the Medicare Payment Advisory Commission, and the Medicaid and CHIP Payment and Access Commission to conduct studies and report to Congress on actions taken to expand access to telehealth services under the Medicare, Medicaid, and Children's Health Insurance programs during the COVID-19 emergency; . S.620 KEEP Telehealth Options Act of 2021; S104 HR379 Improving Social Determinants of Health Act of 2021; H.R.2517, S1125 To recommend that the Center for Medicare and Medicaid Innovation test the effect of a dementia care management model, and for other purposes; H.R.1227, S386 Medicare-X Choice Act of 2021; HR 3322-S826 Medicare Patient Empowerment Act of 2021; HR2410 Medicare & You Handbook Improvement Act of 2021; S1180 Choose Medicare Act' S748 Medicare Sequester Relief Act; HR 315 Medicare Sequester COVID Moratorium Act; HR599 Protecting Medicare Beneficiaries with Pre-Existing Conditions Act.
Client expense: Not reported · Firm income: $11,000
Government targets: Administration on Aging, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
H.R. 2517/S. 1125: A bill to recommend that the Center for Medicare and Medicaid Innovation test the effect of a dementia care management model
H.R.3085/S.1548, the Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act
S.1692/H.R.3354, the Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act
Client expense: $45,000 · Firm income: Not reported
Government targets: Administration on Aging, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
H.R.1677 To direct the Secretary of Health and Human Services, the Medicare Payment Advisory Commission, and the Medicaid and CHIP Payment and Access Commission to conduct studies and report to Congress on actions taken to expand access to telehealth services under the Medicare, Medicaid, and Children's Health Insurance programs during the COVID-19 emergency; . S.620 KEEP Telehealth Options Act of 2021; S104 HR379 Improving Social Determinants of Health Act of 2021; H.R.2517, S1125 To recommend that the Center for Medicare and Medicaid Innovation test the effect of a dementia care management model, and for other purposes; H.R.1227, S386 Medicare-X Choice Act of 2021
Client expense: Not reported · Firm income: $11,000
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $1,310,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $13,100,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $400,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Client expense: Not reported · Firm income: $11,000
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
Client expense: Not reported · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)